Is a PCSK9 Inhibitor Right for Your Patient? A Review of Treatment Data for Individualized Therapy

Introduction: In the United States, a significant amount of the population is affected by hyperlipidemia, which is associated with increased levels of serum low-density lipoprotein (LDL-C) and risk of cardiovascular disease. As of 2019, the guidelines set by the American College of Cardiology/Americ...

Descripción completa

Detalles Bibliográficos
Autores principales: Beltran, Roman A., Zemeir, Kyle J., Kimberling, Chase R., Kneer, Mary S., Mifflin, Michelle D., Broderick, Tom L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779535/
https://www.ncbi.nlm.nih.gov/pubmed/36554779
http://dx.doi.org/10.3390/ijerph192416899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779535/
https://www.ncbi.nlm.nih.gov/pubmed/36554779
http://dx.doi.org/10.3390/ijerph192416899

Ejemplares similares